Sarah Zenner-Dolan

Sarah Zenner-Dolan currently serves as a member of the FDA Peripheral and Central Nervous System Advisory Committee since May 2024 and is an active volunteer with the Critical Path Institute (C-Path) as part of the Clinical Study Endpoints Team since August 2022, contributing to efforts in accelerating therapies for Parkinson’s disease. Additionally, Sarah has held the role of Ambassador at the Davis Phinney Foundation since April 2020, where involvement includes engaging with communities to improve the lives of individuals with Parkinson's through advocacy and education. Sarah earned a Bachelor of Arts degree in English Language and Literature from Saint Louis University in May 1989.